Observational study / 2016
Genetically predicted coffee intake was not associated with type 2 diabetes, ischemic heart disease, depression, or Alzheimer's disease.
Researchers evaluated the effects of genetically predicted coffee consumption on type 2 diabetes mellitus (T2DM), depression, Alzheimer's disease, ischemic heart disease (IHD), and related risk factors using two-sample Mendelian randomization, with childhood cognition as a negative control. Genetically predicted coffee consumption was not associated with T2DM (OR 1.02, 95% CI 0.76 to 1.36), depression (OR 0.89, 95% CI 0.66 to 1.21), Alzheimer's disease (OR 1.17, 95% CI 0.96 to 1.43), IHD (OR 0.96, 95% CI 0.80 to 1.14), lipids, glycemic traits, adiponectin, or childhood cognition. The authors concluded that, contrary to observational findings, coffee may not have beneficial effects on T2DM, depression, or Alzheimer's disease.
Shows an association, not proof of cause and effect.
- Study type
- Two-sample Mendelian randomization study
- Who was studied
- Participants from large genotyped case-control and cross-sectional studies
- What was measured
- T2DM, depression, Alzheimer's disease, IHD and risk factors, childhood cognition
THE PAPER
Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study.
Kwok MK, Leung GM, Schooling CM. Sci Rep, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.